Axovant Gene Therapies Ltd. (AXGT) has 6 open-market insider trades by 3 insiders since 2019. The most active filer is Atul Pande, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. | 10% Owner | — | 1 | $40.0M | 2020-02-24 |
| Pavan Cheruvu | CEO | — | 2 | $245K | 2020-07-08 |
| Atul Pande | Dir | — | 3 | $63K | 2020-07-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Pavan Cheruvu | CEO | Buy | $206K | 2020-07-08 |
| Atul Pande | Director | Buy | $27K | 2020-07-08 |
| Atul Pande | Director | Buy | $18K | 2020-03-16 |
| Roivant Sciences Ltd. | 10% Owner | Buy | $40.0M | 2020-02-24 |
| Pavan Cheruvu | CEO | Buy | $39K | 2019-06-14 |
| Atul Pande | Director | Buy | $18K | 2019-06-14 |
Companies that share insiders with AXGT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.